Aera Therapeutics

Aera Therapeutics is dedicated to advancing the frontier of genetic medicines by addressing their most significant challenge: delivery. We are focused on unlocking the full potential of these transformative therapies through the development of multiple proprietary delivery platforms. Our innovative approaches, including targeted lipid nanoparticles (tLNPs), antibody oligonucleotide conjugates (AOCs), and protein nanoparticles (PNPs), are designed to overcome current limitations and enable next-generation genetic medicines across a diverse range of therapeutic modalities and disease areas.

At Aera Therapeutics, we foster a collaborative and innovative environment where passionate individuals work together to create meaningful scientific advancements. We believe in the power of cutting-edge research to make a profound impact on human health. Explore how Aera Therapeutics is shaping the future of genetic medicine and discover opportunities to join our pioneering team.